Heart Valve Devices Market
Heart Valve Devices Market Analysis by Type (Mechanical Heart Valves, Biological Heart Valve, Transcatheter Valves), by End User (Hospitals, Ambulatory Surgical Centers), by Region - Global Forecast 2022 to 2032
Analysis of Heart Valve Devices market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Heart Valve Devices Market Outlook (2022 to 2032)
The global heart valve devices market is likely to be valued at US$ 11.16 Billion in FY 2022, up from US$ 9.85 Billion in 2021. During the past year, the industry registered a Y-o-Y increase worth 13.3%. From 2022 to 2032, heart valve devices sales are poised to flourish at a CAGR of 13% to reach a value of US$ 37.5 Billion by the end of 2032.
|
Report Attributes |
Details |
|
Anticipated Base Year Value (2021) |
US$ 9.85 Billion |
|
Expected Market Value (2022) |
US$ 11.16 Billion |
|
Projected Forecast Value (2032) |
US$ 37.5 Billion |
|
Global Growth Rate (2022-2032) |
13% CAGR |
|
Growth Rate of the U.S Market (2022-2032) |
13.7% CAGR |
|
Expected Market Value of China (2032) |
US$ 18.5 Billion (Approx.) |
|
U.K Market Expansion Rate (2022-2032) |
12.4% CAGR |
|
Key Companies Profiled |
Edwards Lifesciences Corporation; Braile Biomedica; St. Jude Medical Inc.; Medical Technology Est.; Micro Interventional Devices Inc.; Boston Scientific Corporation; Liva Nova PLC; Cryolife, Inc.; Jena Valve Technology Inc. |
Demand for transcatheter heart valve devices will continue to thrive, with a documented CAGR of 13.1% during the 2015 to 2021 historical period of assessment, while demand for aortic valve biological healthcare devices proliferated at a rate of 13.4% during the same time period. The APAC will dominate the global market, registering a growth opportunity worth US$ 18.5 Billion from 2022 to 2032.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
2015 to 2021 Heart Valve Devices Market Revenue Analysis vs. Market Outlook 2022 to 2032
Fact.MR has predicted the Heart Valve Device market to upswing at 13% CAGR between 2022 and 2032 in comparison to the 13.1% CAGR throughout the historic period.
Sedentary lifestyles, physical inactivity and other habits such as smoking have induced the prevalence of cardiovascular diseases. Subsequently, the demand for minimally invasive procedures to address cardiac anomalies have increased substantially across the globe.
Key Drivers Stimulating Heart Valve Devices Industry Expansion
Increasing Life Expectancy Feature to Act as a Principal Driving Factor
Technological progressions, increasing geriatric population, and an upsurge in prevalence of heart valve disorders (mitral regurgitation and aortic stenosis), growth of innovative repair equipment and rise in minimally invasive techniques demand are some of the foremost factors that are expected to drive growth of heart valves devices market.
Additionally, there has been increment in the healthcare budget of several countries focusing on providing better health infrastructure and facilities. Thus, growing healthcare expenditure, and mounting number of heart surgeries, regarding the diagnosis and availability of treatments for heart valve disorders are likely to boost the demand for the prosthetic heart valves.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Key Challenges to Heart Valve Devices Industry Expansion
Stringent Government Regulations & Expensive Production to Hinder Market Growth
Heart valve replacement, being an invasive process, is linked with possible risk positions as a major factor restraining the cardiac valve market growth. The difficulties associated with replacement surgery comprise excessive bleeding, arrhythmia, kidney problems, stroke, heart failure, infection, clots, and others. Even though, minimally invasive procedures are accessible with less risk and complications; the cost of the surgery is very high when compared to invasive surgery. These difficulties can sternly impact the patient pool undergoing surgery, thereby hampering the market size.
However, stringent government regulations, unavailability of skilled professionals, and repayment issues are some of the key factors limiting growth of the global prosthetic heart valves market.
Country-wise Analysis
How Opportunistic are Growth Prospects across the U.S Market?
Rising Prevalence of Stroke & Cardiac Arrest to Reinforce Demand for Heart Valve Devices
The U.S is projected to continue dominating the global heart valve devices market, registering more than 2/5th of the market share. The prevalence of heart diseases is increasing at a rapid pace around the world. The World health Organization (WHO) affirms cardiovascular diseases as the principal cause of death all over the world. In order to put a lid on the snowballing cases, heart valve devices are necessary.
The Centers for Disease Control and Prevention survey also mentions heart disease as the number one cause of death in the U.S. Rising adoption of technologically advanced heart valve repair devices, in order to reduce treatment duration and procedures are poised to steer market growth.
Also, increasing FDA approvals of transcatheter aortic valves is boosting revenue shares of key market players, thus augmenting the overall heart valve devices market. Fact.MR forecasts that the U.S heart valve devices market is projected to expand at a CAGR of 13.7% to reach US$ 23.7 Billion during the forecast period. Currently, the demand for heart valve devices is proliferating at annual growth rate of 13.2% to reach the market valuation of nearly US$ 6.5 Billion in 2022.
Why are Heart Valve Devices Providers Venturing into China?
Snowballing Geriatric Population to Bolster Demand for Heart Valve Devices in the Region
Fact.MR forecasts that the Asia-Pacific stands at the second spot right next to North America, showing favorable expansion capabilities. Large investment by market players and improvement in healthcare infrastructure are key growth drivers.
In volume terms, mechanical heart devices are projected to capture the maximum market, owing to increased life expectancy and affordable prices. The Asia-Pacific heart valve devices market is set to expand robustly at a CAGR of 14.4% to touch US$ 18.5 Billion mark from the estimated valuation of nearly US$ 4.2 Billion in 2021.
Manufacturers of mechanical heart valve devices are exploring the untapped growth potential in developing countries, owing to a larger pool of cardiovascular disease in the region. These devices ensure longer life expectancy.
The healthcare infrastructure of plentiful Asian countries is improving swiftly. Government bodies are focusing on advancing their healthcare infrastructure to provide improved treatment to its citizens. This factor indirectly benefits in swelling the growth rate of the heart valve devices market.
Country-wise Value CAGRs for Heart Valve Devices (2022 to 2032)
| Countries | CAGR |
|---|---|
| U.S | 13.7% |
| U.K | 12.8% |
| China | 14.4% |
| Japan | 13.1% |
| South Korea | 13.3% |
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Which Heart Valve Type is Most Preferred in the Global Market?
Transcatheter Health Valve to Capture Lion’s Share in the Cardiac Care Market
Transcatheter heart valve devices exhibit a strong growth trajectory during the forecast period. Transcatheter aortic valve replacement is a relatively recent revolutionary treatment that has now become a standard procedure for treating severe aortic stenosis. Rising demand for minimally invasive procedures have prompted players to invest heavily in research and development of new surgical procedures.
Moreover, product launches in transcatheter heart valve prosthesis such as SAPIEN Transcatheter Heart Valve, Magna Ease Aortic and Mitral Valves and PERIMOUNT Aortic/Mitral Valves, are anticipated to boost prospects of transcatheter valves. Fact.MR report summarizes that the market share of more than 40% is predicted for transcatheter heart valves segment, expanding at a CAGR of 8% throughout the forecast period.
As per a report by National Library of medicine, with the development & advancement in the field of transcatheter mitral valve replacement (TMVR), a critical part of evaluating patients with mitral valve disease will be utilizing the heart team approach to identify and individualize the most appropriate treatment for each patient.
How Biological Heart Valve is changing the Growth Prospects for Cardiac Equipment Market?
Increasing Awareness of Prosthetic Devices to Boost Tissue Heart Valve Market
On account of revenue contribution, biological heart valves shall acquire the second-largest market share, capturing nearly one-third of the global heart valve devices market. Augmented usage of biological heart valve grafts among patients below 60 years of age are boosting its demand.
Prevention of formation of blood clots and non-requirement of anti-coagulant medicines are anticipated to bolster the growth of biological heart valves segment. Fact.MR’s latest analytical report reveals that the projected CAGR for biological heart valves is a whopping 9%.
Competitive Landscape
Prominent Heart Valve Devices providers are reliant on partnerships, collaborations, acquisitions, and new software launches so as to stay afloat in the global market. Constant innovations to ensure a seamless client-customer relationship are the main focus of prominent market players.
- In March 2022, Edwards Lifesciences Corporation received approval from the U.S. Food and Drug Administration (FDA) for the MITRIS RESILIA valve, a tissue valve replacement specifically designed for the heart's mitral position.
- In January 2022, CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, made an announcement of renaming and rebranding itself to Artivion, Inc., effective immediately. Derived from the word’s "aorta", "innovation", and "vision", the company's new name and brand reflect its evolution to focus on providing innovative technologies to surgeons who treat patients with aortic disease.
Key Segments Covered in the Heart Valve Devices Industry Survey
-
Heart Valve Devices by Type :
- Mechanical Heart Valves
- Aortic Valve
- Mitral Valve
- Biological Heart Valve
- Aortic Valve
- Mitral Valve
- Pulmonary Valve
- Tricuspid Valve
- Transcatheter Valves
- Aortic Valve
- Mitral Valve
- Pulmonary Valve
- Mechanical Heart Valves
-
Heart Valve Devices by End User :
- Heart Valves in Hospitals
- Heart Valves in Ambulatory Surgical Centers
-
Heart Valve Devices by Region :
- North America Heart Valve Devices Market
- Latin America Heart Valve Devices Market
- Europe Heart Valve Devices Market
- Asia Pacific Heart Valve Devices Market
- Middle East & Africa Heart Valve Devices Market
Table of Content
- 1. Preface
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Market
- 4. Market Overview
- 5. Global Market, Technological Trends
- 6. Global Market, Mergers and Acquisitions, 2015 to 2021
- 7. Global Market, Regulation for Approval of New Medical Devices
- 8. Global Market Analysis and Forecasts, By Type
- 8.1. Mechanical Heart Valves
- 8.1.1. Aortic Valves
- 8.1.2. Mitral Valves
- 8.2. Biological Heart Valves
- 8.2.1. Aortic Valves
- 8.2.2. Mitral Valves
- 8.2.3. Pulmonary Valves
- 8.2.4. Tricuspid Valves
- 8.3. Transcatheter Heart Valves
- 8.3.1. Aortic Valves
- 8.3.2. Mitral Valves
- 8.3.3. Pulmonary Valves
- 8.1. Mechanical Heart Valves
- 9. Global Market Analysis and Forecasts, By End-user
- 9.1. Hospitals
- 9.2. Ambulatory Surgical Centers
- 10. Global Market Analysis and Forecasts, By Region
- 10.1. North America
- 10.2. Europe
- 10.3. Asia Pacific
- 10.4. Latin America
- 10.5. Middle East and Africa
- 11. North America Market Analysis and Forecast
- 12. Europe Market Analysis and Forecast
- 13. Asia Pacific Market Analysis and Forecast
- 14. Latin America Market Analysis and Forecast
- 15. Middle East and Africa Market Analysis and Forecast
- 16. Competition Landscape
- 16.1. Abbott Laboratories
- 16.2. Boston Scientific Corporation
- 16.3. CryoLife, Inc.
- 16.4. Edward Lifesciences Corporation
- 16.5. JenaValve Technology, Inc.
- 16.6. Medtronic
- 16.7. SYMETIS
- 16.8. Neovasc, Inc.
- 16.9. Sorin Group (LivaNova PLC)
- 16.10. Micro Interventional Devices, Inc.
- 16.11. XELTIS
- 16.12. TTK HealthCare
- 16.13. Lepu Medical Technology (Beijing) Co., Ltd. (Lepu Medical Group)
- 16.14. Auto Tissue Berlin GmbH
- 16.15. Novostia SA
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Average Selling Price (US$), by Type, 2022 & 2032
Table 02: Clinical Trials for Transcatheter Aortic Valve Intervention (TAVI), by Company
Table 03: Clinical Trials for Transcatheter Mitral Valve Devices, by Company
Table 04: Clinical Trials for Transcatheter Mitral Valve Devices, by Company
Table 05: Published Patent Details for the Company XELTIS, 2015 to 2021
Table 06: Clinical Trial Details of Xeltis Bioabsorb-able Pulmonary Valved Conduit, 2021
Table 07: Details of the Project – ImaValve, November 2021
Table 08: Overview: Global Market - Acquisitions, by Company, 2021
Table 09: Overview: Global Market - Acquisitions, by Company, 2021
Table 10: Overview: Global Market - Acquisitions, by Company, 2021
Table 11: Overview: Global Market - Acquisitions, by Company, 2021
Table 12: Overview: Global Market - Acquisitions, by Company, 2015
Table 13: Overview: Global Market - Acquisitions, by Company, 2015
Table 14: Overview: Global Market - Merger, by Company, 2015
Table 15: Overview: Global Market - Acquisitions, by Company, 2015 to 2013
Table 16: Overview: Global Market - Acquisitions, by Company, 2015 to 2020
Table 17: Cleared or Approved by U.S. FDA, 2015 to 2020
Table 18: Medical Device Classification as per U.S. FDA
Table 19: Supplements for pre-market approval, by Type of Supplement Process, 1986 to 1997
Table 20: Medical Device Classification as per European Commission (EC)
Table 21: Global Market Value (US$ Mn) Forecast, by Type, 2022 to 2032
Table 22: Global Market Volume (Units) Forecast, by Type, 2022 to 2032
Table 23: Global Market Value (US$ Mn) Forecast, by Mechanical Heart Valves, 2022 to 2032
Table 24: Global Market Volume (Units) Forecast, by Mechanical Heart Valves, 2022 to 2032
Table 25: Global Market Value (US$ Mn) Forecast, by Biological Heart Valves, 2022 to 2032
Table 26: Global Market Volume (Units) Forecast, by Biological Heart Valves, 2022 to 2032
Table 27: Global Market Value (US$ Mn) Forecast, by Transcatheter Heart Valves, 2022 to 2032
Table 28: Global Market Volume (Units) Forecast, by Transcatheter Heart Valves, 2022 to 2032
Table 29: Global Market Value (US$ Mn) Forecast, by End-user, 2015-2025
Table 30: Global Market Value (US$ Mn) Forecast, by Region, 2022 to 2032
Table 31: North America Market Value (US$ Mn) Forecast, by Country, 2022 to 2032
Table 32: North America Market Value (US$ Mn) Forecast, by Type, 2022 to 2032
Table 33: North America Market Volume (Units) Forecast, by Type, 2022 to 2032
Table 34: North America Market Value (US$ Mn) Forecast, by Type, Mechanical Heart Valves, 2022 to 2032
Table 35: North America Market Volume (Units) Forecast, by Type, Mechanical Heart Valves, 2022 to 2032
Table 36: North America Market Value (US$ Mn) Forecast, by Type, Biological Heart Valves, 2022 to 2032
Table 37: North America Market Volume (Units) Forecast, by Type, Biological Heart Valves, 2022 to 2032
Table 38: North America Market Value (US$ Mn) Forecast, by Type, Transcatheter Heart Valves, 2022 to 2032
Table 39: North America Market Volume (Units) Forecast, by Type, Transcatheter Heart Valves, 2022 to 2032
Table 40: North America Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 41: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 to 2032
Table 42: Europe Market Value (US$ Mn) Forecast, by Type, 2022 to 2032
Table 43: Europe Market Volume (Units) Forecast, by Type, 2022 to 2032
Table 44: Europe Market Value (US$ Mn) Forecast, by Mechanical Heart Valves, 2022 to 2032
Table 45: Europe Market Volume (Units) Forecast, by Mechanical Heart Valves, 2022 to 2032
Table 46: Europe Market Value (US$ Mn) Forecast, by Biological Heart Valves, 2022 to 2032
Table 47: Europe Market Volume (Units) Forecast, by Biological Heart Valves, 2022 to 2032
Table 48: Europe Market Value (US$ Mn) Forecast, by Transcatheter Heart Valves, 2022 to 2032
Table 49: Europe Market Volume (Units) Forecast, by Transcatheter Heart Valves, 2022 to 2032
Table 50: Europe Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 51: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 to 2032
Table 52: Asia Pacific Market Value (US$ Mn) Forecast, by Type, 2022 to 2032
Table 53: Asia Pacific Market Volume (Units) Forecast, by Type, 2022 to 2032
Table 54: Asia Pacific Market Value (US$ Mn) Forecast, by Mechanical Heart Valves, 2022 to 2032
Table 55: Asia Pacific Market Volume (Units) Forecast, by Mechanical Heart Valves, 2022 to 2032
Table 56: Asia Pacific Market Value (US$ Mn) Forecast, by Biological Heart Valves, 2022 to 2032
Table 57: Asia Pacific Market Volume (Units) Forecast, by Biological Heart Valves, 2022 to 2032
Table 58: Asia Pacific Market Value (US$ Mn) Forecast, by Transcatheter Heart Valves, 2022 to 2032
Table 59: Asia Pacific Market Volume (Units) Forecast, by Transcatheter Heart Valves, 2022 to 2032
Table 60: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 61: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 to 2032
Table 62: Latin America Market Value (US$ Mn) Forecast, by Type, 2022 to 2032
Table 63: Latin America Market Volume (Units) Forecast, by Type, 2022 to 2032
Table 64: Latin America Market Value (US$ Mn) Forecast, by Type, Mechanical Heart Valves, 2022 to 2032
Table 65: Latin America Market Volume (Units) Forecast, by Type, Mechanical Heart Valves, 2022 to 2032
Table 66: Latin America Market Value (US$ Mn) Forecast, by Type, Biological Heart Valves, 2022 to 2032
Table 67: Latin America Market Volume (Units) Forecast, by Type, Biological Heart Valves, 2022 to 2032
Table 68: Latin America Market Value (US$ Mn) Forecast, by Type, Transcatheter Heart Valves, 2022 to 2032
Table 69: Latin America Market Volume (Units) Forecast, by Type, Transcatheter Heart Valves, 2022 to 2032
Table 70: Latin America Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 71: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 to 2032
Table 72: Middle East & Africa Market Value (US$ Mn) Forecast, by Type, 2022 to 2032
Table 73: Middle East & Africa Market Volume (Units) Forecast, by Type, 2022 to 2032
Table 74: Middle East & Africa Market Value (US$ Mn) Forecast, by Type, Mechanical Heart Valves, 2022 to 2032
Table 75: Middle East & Africa Market Volume (Units) Forecast, by Type, Mechanical Heart Valves, 2022 to 2032
Table 76: Middle East & Africa Market Value (US$ Mn) Forecast, by Type, Biological Heart Valves, 2022 to 2032
Table 77: Middle East & Africa Market Volume (Units) Forecast, by Type, Biological Heart Valves, 2022 to 2032
Table 78: Middle East & Africa Market Value (US$ Mn) Forecast, by Type, Transcatheter Heart Valves, 2022 to 2032
Table 79: Middle East & Africa Market Volume (Units) Forecast, by Type, Transcatheter Heart Valves, 2022 to 2032
Table 80: Middle East & Africa Market Value (US$ Mn) Forecast, by End-user, 2022 to 2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value Share, by Type, 2022 and 2032
Figure 02: Global Mechanical Heart Valve Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022 to 2032
Figure 03: Global Biological Heart Valve Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022 to 2032
Figure 04: Global Transcatheter Heart Valve Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022 to 2032
Figure 05: Global Market Attractiveness, by Type, 2022 to 2032
Figure 06: Global Market Value Share
Figure 07: Global Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2022 to 2032
Figure 08: Global Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 09: Global Market Attractiveness, 2022 to 2032
Figure 10: Global Market Value Share, by Region, 2022 and 2032
Figure 11: Global Market Attractiveness, by Region, 2022 to 2032
Figure 13: North America Market Value Share, by Country, 2022 and 2032
Figure 12: North America Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022 to 2032
Figure 14: North America Market Attractiveness, by Country, 2022 to 2032
Figure 15: North America Market Value Share, by Type, 2022 and 2032
Figure 16: North America Market Attractiveness, by Type, 2022 to 2032
Figure 17: North America Market Value Share, by End-user, 2022 and 2032
Figure 18: North America Market Attractiveness, by End-user, 2022 to 2032
Figure 19: Europe Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022 to 2032
Figure 20: Europe Market Value Share, by Country/Sub-region, 2022 and 2032
Figure 21: Europe Market Attractiveness, by Country/Sub-region, 2022 to 2032
Figure 22: Europe Market Value Share, by Type, 2022 and 2032
Figure 23: Europe Market Attractiveness, by Type, 2022 to 2032
Figure 24: Europe Market Value Share, by End-user, 2022 and 2032
Figure 25: Europe Market Attractiveness, by End-user, 2022 to 2032
Figure 26: Asia Pacific Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022 to 2032
Figure 27: Asia Pacific Market Value Share, by Country/Sub-region, 2022 and 2032
Figure 28: Asia Pacific Market Attractiveness, by Country/Sub-region, 2022 to 2032
Figure 29: Asia Pacific Market Value Share, by Type, 2022 and 2032
Figure 30: Asia Pacific Market Attractiveness, by Type, 2022 to 2032
Figure 31: Asia Pacific Market Value Share, by End-user, 2022 and 2032
Figure 32: Asia Pacific Market Attractiveness, by End-user, 2022 to 2032
Figure 33: Latin America Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022 to 2032
Figure 34: Latin America Market Value Share, by Country/Sub-region, 2022 and 2032
Figure 35: Latin America Market Attractiveness, by Country/Sub-region, 2022 to 2032
Figure 36: Latin America Market Value Share, by Type, 2022 and 2032
Figure 37: Latin America Market Attractiveness, by Type, 2022 to 2032
Figure 38: Latin America Market Value Share, by
Figure 39: Latin America Market Attractiveness, by End-user, 2022 to 2032
Figure 40: Middle East & Africa Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022 to 2032
Figure 41: Middle East & Africa Market Value Share, by Country/Sub-region, 2022 and 2032
Figure 42: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2022 to 2032
Figure 43: Middle East & Africa Market Value Share, by Type, 2022 and 2032
Figure 44: Middle East & Africa Market Attractiveness, by Type, 2022 to 2032
Figure 45: Middle East & Africa Market Value Share, by End-user, 2022 and 2032
Figure 46: Middle East & Africa Market Attractiveness, by End-user, 2022 to 2032
Figure 47: Global Market Share, by Company, 2021
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What was the market worth for heart valve devices in 2021?
As of 2021, Fact.MR estimated the heart valve devices market to have reached US$ 9.85 Billion
What is the expected worth of the heart valve devices industry in 2022?
By 2022, Fact.MR expected demand for heart valve devices to reach US$ 11.16 Billion
At what rate did the heart valve devices market flourish from 2015-2021?
From 2015-2021, the heart valve devices market grew at a 13.1% value CAGR
What is the expected forecast CAGR for heart valve devices from 2022-2032?
From 2022-2032, heart valve devices demand is likely to surge at a 13% CAGR
At what value will the market for heart valve devices close in 2032?
By 2032, the market for heart valve devices is likely to be valued at US$ 37.5 Billion
What is the expected market value for the U.S heart valve devices market?
By 2032, Fact.MR expects the U.S market for heart valve devices to reach US$ 23.7 Billion
How opportunistic is the Chinese market for heart valve devices?
China is expected to register a 14.4% CAGR with regard to the heart valve devices industry
What are the expected growth rates for the South Korean and Japanese markets?
South Korea and Japan are expected to document CAGRs worth 13.1% and 13.4% respectively in the Heart Valve Devices market
Which product type will account for the maximum heart valve devices revenue?
Transcatheter heart valve devices will be maximum, expanding at an 8% CAGR
By type, which category is likely to remain top-selling until 2032?
Biological heart valve devices will gain traction, expanding at a CAGR of whooping 13% until 2032
Heart Valve Devices Market